Australia's 60-day prescriptions are saving millions; why aren't more patients getting them?
Millions are saving money with Australia's 60-day prescriptions, but uptake remains low — here's why many patients still aren't accessing the benefit.
The Prescription Policy Saving Australians Millions That Most Patients Still Don't Know About
Most people assume the hardest part of managing a chronic condition is the diagnosis. But straight up, for millions of Australians, it's actually the ongoing cost of medication that causes the most stress. That's why a policy linked to long-term conditions, including those affecting hormones like low t (low testosterone) and cardiovascular health, should be front-page news. And yet, two years in, Australia's 60-day dispensing policy is being dramatically underused.
What Is the 60-Day Dispensing Policy, Exactly?
In September 2023, the Australian government decided to tweak its Pharmaceutical Benefits Scheme. Now eligible folks can snag a 60-day supply of certain meds in one go. Before this, most of us were grabbing 30-day packs and shelling out cash every month.
Editor's Pick
We Tested Dozens. These 5 Actually Work.
After months of research and real-world testing, we put together a no-fluff ranking of the most effective supplements in this category for men over 40.
See Our Top 5 T-Boosters →Doubling the supply time cuts down pharmacy trips by half. If you're on a standard co-payment, it's a nice chunk of change saved. And for those with concession cards, some meds might even end up costing zilch after you hit a certain point. That's actually not nothing.
So the financial upside is obvious. The question is why it's not reaching people.
New Research Reveals a Significant Adoption Gap
A study published in the Medical Journal of Australia looked specifically at uptake of 60-day dispensing for blood pressure medicines over the two years since the policy launched. The findings were, to be fair, pretty damning.
GPs and pharmacists have been slow to adopt the policy. Despite the clear cost benefit for patients, the research found that the rollout has fallen well short of its potential. Patients eligible under the scheme are still routinely receiving 30-day supplies.
That's not a minor administrative issue. It represents millions of dollars in unnecessary out-of-pocket costs for people managing long-term conditions.
Why Are GPs and Pharmacists Slow to Adopt It?
Here's the thing. Change in healthcare systems is notoriously slow, even when the evidence is solid and the benefit is obvious. Several factors are likely at play.
- Prescribing habits are deeply ingrained. Many GPs have written 30-day scripts for decades.
- Some pharmacists initially raised concerns about cash flow, since dispensing fees are tied to each transaction.
- Patient awareness is low. If a patient doesn't ask, many practitioners don't raise it.
- Software and workflow updates in some practices have lagged behind the policy change.
Honestly, the pharmacist incentive problem is worth taking seriously. Dispensing fees represent real income for community pharmacies, and halving the number of dispensing events does have a financial impact. That tension was known before the policy launched and arguably wasn't resolved well enough at the outset.
Which Medicines Are Currently Eligible?
The initial list was all about stable, long-term conditions. Blood pressure meds got the nod early on. Since then, it's grown. Basically, they're focusing on meds for things that don't go away overnight.
- Hypertension and cardiovascular disease
- Type 2 diabetes management
- Cholesterol-lowering therapies
- Mental health conditions including depression and anxiety
- Thyroid conditions
Testosterone replacement therapy might make the cut, depending on the specifics. If you're tackling a long-term hormonal issue, just ask your GP if your script is good for the 60-day deal. It's not exactly rocket science.
For men exploring non-prescription support for energy, libido, or vitality alongside their conventional care, checking out a ranked review of the best ED supplements in 2026 can help separate evidence-based options from marketing noise.
The Real-World Cost Impact for Patients
Let's crunch some numbers. In 2024, under the standard PBS co-payment, general patients are paying about $31 per script. Concession cardholders cough up around $7.70. Stick with the 30-day routine and you fill 12 scripts a year. Switch to 60-day and you're down to 6, saving about $186 per medicine annually. Not too shabby.
For patients on multiple long-term medicines, the savings can be substantial. If you're juggling meds for hypertension, high cholesterol, and blood sugar, think about this. Switching how often you get them could save you over $500 a year. That's real money.
That's not a trivial amount for anyone, but it's especially significant for older Australians on fixed incomes.
What Patients Can Do Right Now
Don't wait for your GP or pharmacist to bring it up. Be proactive. At your next appointment, ask specifically whether any of your regular medicines are eligible for 60-day dispensing under the PBS.
If you're managing a chronic hormonal condition and also dealing with related concerns like fatigue, reduced drive, or cardiovascular risk, staying informed about both pharmaceutical and complementary options matters. A detailed review of Boostaro covers one popular supplement that's been discussed in the men's health space, alongside real results.
According to Healthdirect Australia, patients are encouraged to discuss any PBS concessions and dispensing options with their prescriber at every medication review.
The Bigger Picture: Health Policy and Chronic Disease
Australia's grappling with more chronic diseases these days. High blood pressure, metabolic issues, and hormone whackiness top the list. So, cutting the costs to stick with treatment? In theory, it should boost overall health for everyone. But, we'll see how that plays out.
But policy only works if it's actually used. And right now, this one isn't being used nearly enough.
Here's the thing: health systems everywhere can learn a lot from this. Designing a solid policy is just the start. You need education campaigns, incentives for docs, and commitment to make it work. Without that, even the best plans fall short.
For men navigating low testosterone, cardiovascular risk, or related conditions, understanding both your PBS entitlements and the evidence around supportive supplements like those reviewed in this science-based look at Boostaro can help you take a more complete approach to long-term health.
Frequently Asked Questions
What is 60-day dispensing in Australia?
60-day dispensing is a PBS policy letting certain patients snag a two-month supply of meds in one go, chopping down co-pay costs. It kicked off in September 2023 and covers an expanding list of meds for stable, long-term conditions.
How do I know if my medicine qualifies for 60-day dispensing?
The best way to check is to ask your GP or pharmacist directly at your next appointment. The PBS website also maintains an updated list of eligible medicines, and your prescriber can flag eligibility on the script itself.
Why hasn't my doctor mentioned the 60-day dispensing option?
Research from the Medical Journal of Australia shows GPs and pharmacists are dragging their feet. Many haven't tweaked their prescribing habits, so folks miss out because nobody's mentioning it. That's frustrating, right?
Does 60-day dispensing affect the quality or safety of my medicine?
No. Receiving a 60-day supply doesn't change the medicine itself in any way. The same quality, dose, and formulation applies. Storage instructions remain the same, and your pharmacist can